Filter by:
The review on tobacco and tobacco smoking indicators in France brings together recent figures which vary in nature and origin. The annual 2015 review on tobacco has been drawn up from the monthly reports and presents them as a concise overview.
Studies on social cost allow public authorities to evaluate the economic burden of a social problem on the community.
The use of morphine sulphate outside of the scope of the therapeutic framework is not a new phenomenon. However, starting in 2000 and for a decade thereafter, such use appeared to be fairly controlled, geographically-contained and volatile over time. Since 2011 or so, there has been a rise in demand that is disparate, but geographically widespread.
This briefing produced by the OFDT's TREND (Emerging trends and new drugs) Unit focuses on ketamine, a veterinary and human anaesthetic.
While electronic cigarette use seems to be rising sharply in France since 2012, data on the prevalence and modalities of electronic cigarette use are still fragmented.
As the most widely-used illegal substance in France, more than one third of French 17-year-olds had used cannabis in the last year in 2011, and 7 out of 100 of them used it regularly (at least 10 times in the last month).